Cytomedix Files Application With FDA for AutoloGel(tm) System in Orthopedics
07. August 2009 07:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company") announces the filing of a 510(k) premarket notification with the U.S. Food and Drug Administration...
Cytomedix Announces Acceptance by NYSE Amex of Plan of Compliance
29. Juli 2009 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., July 29, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) (the "Company"), announces receipt of a letter from NYSE Amex LLC (the "Exchange") indicating that the Exchange has...
Cytomedix Announces the Publication of a New AutoloGel(tm) Case Series in the Journal WOUNDS
27. Mai 2009 12:04 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., May 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) today announced the publication in WOUNDS of a paper entitled "Double impact": Synergism in using Negative Pressure...
Cytomedix Receives a NYSE Amex Listing Deficiency Notification
14. Mai 2009 16:57 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., May 14, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), today announced that on May 13, 2009 it received notice from the NYSE Amex (the "Exchange") notifying the Company it...
Cytomedix to Exhibit At the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) Meeting April 26-29, 2009
23. April 2009 10:44 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., April 23, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), today announced that it will be exhibiting at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing...
Cytomedix CEO Discusses the Company and His Leadership Style in an Interview On The Leaders Spot With Rebecca Blacksmith
09. April 2009 14:26 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., April 9, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer Martin Rosendale discussed the company and his leadership style in an...
Cytomedix CEO Issues Shareholder Update
31. März 2009 16:29 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., March 31, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) announced today that Chief Executive Officer Martin Rosendale issued the following letter to shareholders providing a...
Cytomedix, Inc. Reports Year-End 2008 Financial Results
31. März 2009 16:29 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., March 31, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) today reported financial results for the year ended December 31, 2008.
On March 31, 2009, the Company filed with...
Cytomedix Further Strengthens Its Board of Directors
05. Februar 2009 12:10 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Feb. 5, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Alternext US:GTF) announced today that it has appointed C. Eric Winzer to its Board of Directors; Mr. Winzer will also serve as...
Cytomedix Announces Publication of Economic Model Indicating Cost-Effectiveness of AutoloGel(tm) for Diabetic Foot Ulcers
10. Dezember 2008 13:45 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Dec. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Alternext US: GTF) announced today that a cost-effectiveness analysis comparing the Company's Platelet Rich Plasma (PRP) gel,...